BI 836845 in Estrogen Receptor Positive Metastatic Breast Cancer
Clinical trial NCT02123823 · COMPLETED
Trial details
- NCT number
- NCT02123823
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-15
- Primary completion
- 2016-11-25
- Enrollment
- 164
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.